Your browser doesn't support javascript.
loading
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma.
Farah, Maya; Reuben, Alexandre; Spassova, Ivelina; Yang, Richard K; Kubat, Linda; Nagarajan, Priyadharsini; Ning, Jing; Li, Wen; Aung, Phyu P; Curry, Jonathan L; Torres-Cabala, Carlos A; Hudgens, Courtney W; Ugurel, Selma; Schadendorf, Dirk; Gumbs, Curtis; Little, Latasha D; Futreal, Andrew; Wistuba, Ignacio I; Prieto, Victor G; Wang, Linghua; Wong, Michael K; Wargo, Jennifer A; Becker, Jürgen C; Tetzlaff, Michael T.
Afiliação
  • Farah M; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reuben A; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Spassova I; Translational Skin Cancer Research, University Clinic Essen, Essen, Germany.
  • Yang RK; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kubat L; Translational Skin Cancer Research, University Clinic Essen, Essen, Germany.
  • Nagarajan P; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Li W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Aung PP; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Curry JL; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Translational and Molecular Pathology, The University of Texas MD
  • Torres-Cabala CA; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hudgens CW; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ugurel S; Department of Dermatology, University Clinic Essen, Essen, Germany.
  • Schadendorf D; Department of Dermatology, University Clinic Essen, Essen, Germany.
  • Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Little LD; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wistuba II; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Prieto VG; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wargo JA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Becker JC; Translational Skin Cancer Research, University Clinic Essen, Essen, Germany; Department of Dermatology, University Clinic Essen, Essen, Germany; German Cancer Consortium, German Cancer Center, Heidelberg, Germany.
  • Tetzlaff MT; Department of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: mtetzlaff@mdanderson.org.
J Invest Dermatol ; 140(11): 2146-2156.e4, 2020 11.
Article em En | MEDLINE | ID: mdl-32304704
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptores de Antígenos de Linfócitos T / Linfócitos T / Carcinoma de Célula de Merkel Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptores de Antígenos de Linfócitos T / Linfócitos T / Carcinoma de Célula de Merkel Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Invest Dermatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos